UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000013668
Receipt number R000014898
Scientific Title Deferred combined androgen blockade therapy using antiandrogen in metastatic prostate cancer patients treated with GnRH antagonist, degarelix
Date of disclosure of the study information 2014/04/08
Last modified on 2019/01/28 17:19:19

No. Disposal Last modified on Item of update
1 Insert 2014/04/08 14:34:28
2 Update 2014/08/13 11:32:03 Key secondary outcomes
3 Update 2014/08/13 11:33:59 Date of protocol fixation
Anticipated trial start date
4 Update 2014/08/13 11:39:33 Key exclusion criteria
Key exclusion criteria
5 Update 2014/08/26 15:35:47 Condition
Narrative objectives1
Primary outcomes
Key secondary outcomes
6 Update 2014/08/26 16:45:55 Key exclusion criteria
Key exclusion criteria
7 Update 2014/10/14 10:09:46 Last name of contact person
Last name of contact person
Division name
Division name
Email
8 Update 2017/10/18 14:42:34 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
9 Update 2017/10/18 14:43:04 UMIN ID1
10 Update 2018/04/12 11:51:35 Name of primary person or sponsor
Organization
Address1
Email1
11 Update 2019/01/28 17:18:32 Date of closure to data entry
Date trial data considered complete
Date analysis concluded
12 Update 2019/01/28 17:19:19 Recruitment status